Accrol Group Holdings PLC Appointment of Joint Broker (0581S)

TIDMACRL

RNS Number : 0581S

Accrol Group Holdings PLC

07 March 2023

7 March 2023

Accrol Group Holdings plc

("Accrol", the "Group" or the "Company")

APPOINTMENT OF JOINT BROKER

Accrol Group, the UK's leading independent tissue converter, is pleased to announce the appointment of Shore Capital Stockbrokers as Joint Broker, to work alongside Zeus, the Company's Nominated Adviser and Joint Broker, with immediate effect.

 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman            Via Belvedere Communications 
Gareth Jenkins, Chief Executive Officer 
 Richard Newman, Chief Financial Officer 
 
Zeus (Nominated Adviser & Joint Broker) 
Dan Bate / Jordan Warburton                  Tel: [phone] 
Dominic King                                 Tel: [phone] 
 
Shore Capital Stockbrokers (Joint            Tel: [phone] 
 Broker) 
Malachy McEntyre / Mark Percy / James 
 Thomas 
 
Belvedere Communications Limited 
Cat Valentine                                Tel: [phone] 
Keeley Clarke                                Tel: [phone] 
                                              [e-mail] 
 

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which together supply c.21.5% (volume) of the UK tissue market valued at cGBP2.5bn at retail sales value.

For more information, please visit www.accrol.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPDQLFBXXLBBBX

(END) Dow Jones Newswires

March 07, 2023 02:00 ET (07:00 GMT)